DK1282625T3 - Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom - Google Patents

Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom

Info

Publication number
DK1282625T3
DK1282625T3 DK01925065T DK01925065T DK1282625T3 DK 1282625 T3 DK1282625 T3 DK 1282625T3 DK 01925065 T DK01925065 T DK 01925065T DK 01925065 T DK01925065 T DK 01925065T DK 1282625 T3 DK1282625 T3 DK 1282625T3
Authority
DK
Denmark
Prior art keywords
benzoxazines
parkinson
disease
treatment
alkyl
Prior art date
Application number
DK01925065T
Other languages
English (en)
Inventor
Corrine Elizab Augelli-Szafran
Roy Douville Schwarz
Thomas Boehme
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1282625T3 publication Critical patent/DK1282625T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK01925065T 2000-05-09 2001-04-17 Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom DK1282625T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20278700P 2000-05-09 2000-05-09
PCT/US2001/012528 WO2001085734A1 (en) 2000-05-09 2001-04-17 Benzoxazines for use in the treatment of parkinson's disease
EP01925065A EP1282625B1 (en) 2000-05-09 2001-04-17 Benzoxazines for use in the treatment of parkinson's disease

Publications (1)

Publication Number Publication Date
DK1282625T3 true DK1282625T3 (da) 2004-11-15

Family

ID=22751255

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01925065T DK1282625T3 (da) 2000-05-09 2001-04-17 Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom

Country Status (13)

Country Link
US (1) US6812228B2 (da)
EP (1) EP1282625B1 (da)
JP (1) JP2003532733A (da)
AT (1) ATE270295T1 (da)
AU (1) AU2001251662A1 (da)
BR (1) BR0110643A (da)
CA (1) CA2407789A1 (da)
DE (1) DE60104110T2 (da)
DK (1) DK1282625T3 (da)
ES (1) ES2223824T3 (da)
MX (1) MXPA02010270A (da)
PT (1) PT1282625E (da)
WO (1) WO2001085734A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8593722B2 (en) 2011-07-05 2013-11-26 Electro Scientific Industries, Inc. Systems and methods for providing temperature stability of acousto-optic beam deflectors and acousto-optic modulators during use
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders

Also Published As

Publication number Publication date
ES2223824T3 (es) 2005-03-01
EP1282625B1 (en) 2004-06-30
ATE270295T1 (de) 2004-07-15
PT1282625E (pt) 2004-10-29
DE60104110T2 (de) 2005-08-25
MXPA02010270A (es) 2003-04-25
EP1282625A1 (en) 2003-02-12
BR0110643A (pt) 2003-03-18
WO2001085734A1 (en) 2001-11-15
US20030220335A1 (en) 2003-11-27
US6812228B2 (en) 2004-11-02
CA2407789A1 (en) 2001-11-15
AU2001251662A1 (en) 2001-11-20
JP2003532733A (ja) 2003-11-05
DE60104110D1 (de) 2004-08-05

Similar Documents

Publication Publication Date Title
JO2668B1 (en) Isoczazolins for controlling invertebrate insects
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
GB0318343D0 (en) No title
GB0318447D0 (en) Therapeutic agents
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
GB0318438D0 (en) Early entry
GB0225475D0 (en) Therapeutic agents
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
PT1003725E (pt) Fungicidas de fluoropirazoldifenilamidas
DK1696905T3 (da) Substituerede 2-aminotetraliner til forebyggende behandling af Morbus Parkinson
MXPA03000450A (es) Sulfonamidas de ciclilamina como agonistas del receptor adrenergico beta-3.
MXPA05007115A (es) Nuevos agonistas inversos del receptor cb 1.
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
NO20065902L (no) 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler
MXPA04006041A (es) Antivirales de piridoquinoxalina.
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
DE60112960D1 (de) Kondensierte pyridoindolderivate
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
DK1282625T3 (da) Anvendelsen af benzoxaziner i behandlingen af Parkinsons sygdom
PE20050254A1 (es) N-[3-(3-SUSTITUIDAS-PIRAZOLO [1,5-a]PIRIMIDIN-7-IL) FENIL]-SULFONAMIDAS Y COMPOSICIONES RELACIONADAS
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
CO5170464A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano